Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeranuhi Hovhannisyan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Cell Physiology|February 6, 2020
Synemin-related skeletal and cardiac myopathies: an overview of pathogenic variantsDenise Paulin, Yeranuhi Hovhannisyan, Serdar Kasakyan, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
Polyacrylamide Hydrogels with Rigidity-Independent Surface Chemistry Show Limited Long-Term Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells on Soft SubstratesSolenne Paiva, Pierre Joanne, Camille Migdal, et al.
High-Throughput|February 16, 2020
Rational Engineering of the Substrate Specificity of a Thermostable D-Hydantoinase (Dihydropyrimidinase)Hovsep Aganyants, Pierre Weigel, Yeranuhi Hovhannisyan, et al.
Stem Cell Research|November 30, 2023
Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9Caterina Gargano, Jean-Sébastien Vartanian-Grimaldi, Yeranuhi Hovhannisyan, et al.
Plos One|April 24, 2019
Effects of the selective inhibition of proteasome caspase-like activity by CLi a derivative of nor-cerpegin in dystrophic mdx miceYeranuhi Hovhannisyan, Gagik Melikyan, Nathalie Mougenot, et al.
Stem Cell Research|February 14, 2024
Generation of human induced pluripotent stem cell lines from five patients with Myofibrillar myopathy carrying different heterozygous mutations in the DES genePierre Joanne, Yeranuhi Hovhannisyan, Alexandre Simon, et al.
The Journal of Physiology|June 10, 2020
Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouseArnaud Ferry, Julien Messéant, Ara Parlakian, et al.
Frontiers in Cell and Developmental Biology|August 2, 2021
Absence of Desmin Results in Impaired Adaptive Response to Mechanical Overloading of Skeletal MusclePierre Joanne, Yeranuhi Hovhannisyan, Maximilien Bencze, et al.
Acta Physiologica (Oxford, England)|October 30, 2025
Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy-Associated CardiomyopathyBrice-Emmanuel Guennec, Yeranuhi Hovhannisyan, Gaëlle Revet, et al.
Stem Cell Research & Therapy|February 27, 2026
Desmin mutations in cardiomyocytes increase susceptibility to coxsackievirus B3 infection by impairing antiviral IFN-β response and upregulating viral receptors expressionDomitille Callon, Yeranuhi Hovhannisyan, Gabriel Friob, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Cell Physiology|February 6, 2020
Synemin-related skeletal and cardiac myopathies: an overview of pathogenic variantsDenise Paulin, Yeranuhi Hovhannisyan, Serdar Kasakyan, et al.
ACS Biomaterials Science & Engineering|January 19, 2021
Polyacrylamide Hydrogels with Rigidity-Independent Surface Chemistry Show Limited Long-Term Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells on Soft SubstratesSolenne Paiva, Pierre Joanne, Camille Migdal, et al.
High-Throughput|February 16, 2020
Rational Engineering of the Substrate Specificity of a Thermostable D-Hydantoinase (Dihydropyrimidinase)Hovsep Aganyants, Pierre Weigel, Yeranuhi Hovhannisyan, et al.
Stem Cell Research|November 30, 2023
Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9Caterina Gargano, Jean-Sébastien Vartanian-Grimaldi, Yeranuhi Hovhannisyan, et al.
Plos One|April 24, 2019
Effects of the selective inhibition of proteasome caspase-like activity by CLi a derivative of nor-cerpegin in dystrophic mdx miceYeranuhi Hovhannisyan, Gagik Melikyan, Nathalie Mougenot, et al.
Stem Cell Research|February 14, 2024
Generation of human induced pluripotent stem cell lines from five patients with Myofibrillar myopathy carrying different heterozygous mutations in the DES genePierre Joanne, Yeranuhi Hovhannisyan, Alexandre Simon, et al.
The Journal of Physiology|June 10, 2020
Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouseArnaud Ferry, Julien Messéant, Ara Parlakian, et al.
Frontiers in Cell and Developmental Biology|August 2, 2021
Absence of Desmin Results in Impaired Adaptive Response to Mechanical Overloading of Skeletal MusclePierre Joanne, Yeranuhi Hovhannisyan, Maximilien Bencze, et al.
Acta Physiologica (Oxford, England)|October 30, 2025
Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy-Associated CardiomyopathyBrice-Emmanuel Guennec, Yeranuhi Hovhannisyan, Gaëlle Revet, et al.
Stem Cell Research & Therapy|February 27, 2026
Desmin mutations in cardiomyocytes increase susceptibility to coxsackievirus B3 infection by impairing antiviral IFN-β response and upregulating viral receptors expressionDomitille Callon, Yeranuhi Hovhannisyan, Gabriel Friob, et al.
Pageof 2